tysabri
biogen netherlands b.v. - natalizumab - multiple sklerose - selektive immunsuppressiva - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 und 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
zinbryta
biogen idec ltd - daclizumab - multiple sklerose - immunsuppressiva - zinbryta ist bei erwachsenen patienten zur behandlung von schubförmig verlaufenden formen der multiplen sklerose (rms) indiziert..
spinraza
biogen netherlands b.v. - nusinersen-natrium - muskelatrophie, spinal - andere medikamente des nervensystems - spinraza ist indiziert zur behandlung der 5q spinalen muskelatrophie.
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - multiple sklerose, schubförmig-remittierender - immunsuppressiva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
imipenem/cilastatin aptapharma 500 mg/500 mg pulver zur herstellung einer infusionslösung
apta medica internacional d.o.o. - cilastatin natrium; imipenem monohydrat -
ertapenem aptapharma 1 g pulver für ein konzentrat zur herstellung einer infusionslösung
apta medica internacional d.o.o. - ertapenem natrium -
cefazolin aptapharma 1 g pulver zur herstellung einer injektions-/infusionslösung
apta medica internacional d.o.o. - cefazolin natrium -
amoxicillin/clavulansäure aptapharma 1000 mg/200 mg pulver zur herstellung einer injektions-/infusionslösung
apta medica internacional d.o.o. - kaliumclavulanat; natrium amoxicillinat -
meropenem aptapharma 2000 mg pulver zur herstellung einer infusionslösung
apta medica internacional d.o.o. - meropenem trihydrat -
sugammadex aptapharma 100 mg/ml injektionslösung
apta medica internacional - sugammadex-octanatrium -